Answers are grounded in this paper and cite their sources.
Observational analysis reports increasing extrapulmonary tuberculosis cases in Germany, highlighting challenges in diagnosis and treatment.
In 2023, tuberculosis (TB) caused 1.25 million deaths among 10.8 million cases, remaining the deadliest infectious disease worldwide. In Germany, incidence declined for decades but rose slightly in 2022-2023, driven mainly by migration from high-prevalence countries (e.g., Syria, Afghanistan, Ukraine). While most cases are pulmonary TB (PTB), 22.8% are extrapulmonary TB (EPTB), which can affect any organ and is often hard to diagnose due to nonspecific symptoms. Diagnosis uses microscopy, PCR, and culture; treatment typically lasts at least 6 months, extended for CNS, bone, or miliary TB. Treatment response is assessed clinically and radiologically; reliable blood-based markers are urgently needed.
No takes yet. Share an insight, caveat, or question.
Klingmüller et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: